Citations

Institution: Mayo Clinic Clear

Showing 10 of 108152 citations.

The Perils of Deprofessionalizing Laboratory Test Ordering: Are We Headed Down a Costly Path?
Mills, John R. , Katzman, Brooke M. , Baumann, N

Clinical Chemistry | August 28, 2015 | Volume: 61 | Issue: 9 | Pages: 1216-1217

10.1373/clinchem.2015.242222 Get It

Molecular Testing in Anatomic Pathology and Adherence to Guidelines: A College of American Pathologists Q-Probes Study of 2230 Testing Events Reported by 26 Institutions
Volmar, Keith E., Souers, Rhona J., Nakhleh, Raouf E. , Idowu, Michael O.

Archives of Pathology & Laboratory Medicine | August 28, 2015 | Volume: 139 | Issue: 9 | Pages: 1115-1124

10.5858/arpa.2014-0513-cp | PMID 26317453 Get It

Context The appropriate and timely performance of molecular testing in anatomic pathology is an indicator of quality. The National Comprehensive Cancer Network (NCCN) publishes a comprehensive treatment guideline that includes recommendations for ancillary testing. Objective To establish benchmarks for rates of adherence to NCCN testing recommendations through a multi-institutional study. Design Participants in a 2013 Q-Probes study of the College of American Pathologists reported data from molecular testing on anatomic pathology cases, excluding hematolymphoid neoplasms, breast primary carcinomas, and gynecologic cytology. Results Twenty-six institutions reported data from 2230 molecular testing events. In a retrospective study limited to colon, lung, and melanoma, there was strict adherence to guidelines in a median 71% (10th to 90th percentile range, 33%–90%) and there was at least loose adherence in a median 95% (10th to 90th percentile range, 57%–100%). There was adequate tissue to complete testing in a median 98% (10th to 90th percentile range, 86%–100%); in aggregate the adequacy rate for cell blocks was lower (84%, P < .001). Median test turnaround time was 8 days (10th to 90th percentile range, 4–13 days). In a prospective collection of all organ sites, there was strict adherence to guidelines in a median 53% (10th to 90th percentile range, 20%–71%), and there was at least loose adherence in a median 94% (10th to 90th percentile range, 75%–100%). Adherence to guidelines was higher for lung specimens and in institutions with more multidisciplinary conferences. Conclusions This multi-institutional study provides benchmarking data on appropriateness and timeliness of molecular testing in anatomic pathology.
Differentiating Germline vs Somatic Variants in Cancer Tissue: Are Large-Panel Genetic Tests Helping or Hurting the Cancer Patient?
Kipp, Benjamin R.

Clinical Chemistry | August 28, 2015 | Volume: 61 | Issue: 9 | Pages: 1215-1216

10.1373/clinchem.2015.242768 Get It

Association of traumatic brain injury with subsequent neurological and psychiatric disease: a meta-analysis
Perry, David C. , Sturm, Virginia E. , Peterson, Matthew J. , Pieper, Carl F. , Bullock, T., Kramer, Joel H. , Boeve, Bradley F. , Miller, Bruce L. , Guskiewicz, Kevin M. , Berger, Mitchel S. , Welsh-Bohmer, Kathleen Anne

Journal of Neurosurgery | August 28, 2015 | Volume: 124 | Issue: 2 | Pages: 511-526

10.3171/2015.2.jns14503 | PMID 26315003 Get It

OBJECT Mild traumatic brain injury (TBI) has been proposed as a risk factor for the development of Alzheimer’s disease, Parkinson’s disease, depression, and other illnesses. This study’s objective was to determine the association of prior mild TBI with the subsequent diagnosis (that is, at least 1 year postinjury) of neurological or psychiatric disease. METHODS All studies from January 1995 to February 2012 reporting TBI as a risk factor for diagnoses of interest were identified by searching PubMed, study references, and review articles. Reviewers abstracted the data and assessed study designs and characteristics. RESULTS Fifty-seven studies met the inclusion criteria. A random effects meta-analysis revealed a significant association of prior TBI with subsequent neurological and psychiatric diagnoses. The pooled odds ratio (OR) for the development of any illness subsequent to prior TBI was 1.67 (95% CI 1.44–1.93, p < 0.0001). Prior TBI was independently associated with both neurological (OR 1.55, 95% CI 1.31–1.83, p < 0.0001) and psychiatric (OR 2.00, 95% CI 1.50–2.66, p < 0.0001) outcomes. Analyses of individual diagnoses revealed higher odds of Alzheimer’s disease, Parkinson’s disease, mild cognitive impairment, depression, mixed affective disorders, and bipolar disorder in individuals with previous TBI as compared to those without TBI. This association was present when examining only studies of mild TBI and when considering the influence of study design and characteristics. Analysis of a subset of studies demonstrated no evidence that multiple TBIs were associated with higher odds of disease than a single TBI. CONCLUSIONS History of TBI, including mild TBI, is associated with the development of neurological and psychiatric illness. This finding indicates that either TBI is a risk factor for heterogeneous pathological processes or that TBI may contribute to a common pathological mechanism.
Meeting report: discussions and preliminary findings on extracellular RNA measurement methods from laboratories in the NIH Extracellular RNA Communication Consortium
Laurent, Louise C. , Abdel‐Mageed, Asim B. , Adelson, P. David , Arango, Jorge , Balaj, Leonora , Breakefield, Xandra O., Carlson, Elizabeth, Majem, Blanca , Chen, Clark C. , Cocucci, Emanuele , Danielson, Kirsty , Courtright, Amanda, Das, Saumya , Enderle, Daniel , Ezrin, Alan M., Galas, David J. , Gandhi, Roopali, Huentelman, Matthew J. , Keuren‐Jensen, Kendall Van , Kalani, Yashar, Kim, Yong , Krichevsky, Anna M. , Lai, Charles Pin‐Kuang , Lal‐Nag, Madhu , Laurent, Clara D., Leonardo, Trevor R. , Malenica, Ivana , Mondal, Debasis , Nejad, Parham, Raffaı̈, Robert L. , Rubio, Renee, Skog, Johan , Spetzler, Robert, Sun, Jie , Tanrıverdi, Kahraman , Vickers, Kasey C. , Wang, Yaoyu, Weiner, Howard L. , Yeri, Ashish, Gould, Stephen J. , Breakefield, Xandra O. , Courtright-Lim, Amanda , Yan, Irene K. , Laurent, Louise C , Carter, Bob S. , Elmageed, Zakaria Y. Abd , Ferrer, Marc , Freedman, Jane E. , Li, Feng , Patel, Tushar , Wang, Liang , Wang, Yaoyu, Wei, Zhiyun , Wong, David T.

Journal of Extracellular Vesicles | August 28, 2015 | Volume: 4 | Issue: 1 | Pages: No page available

10.3402/jev.v4.26533 | PMID 26320937 Get It

Extracellular RNAs (exRNAs) have been identified in all tested biofluids and have been associated with a variety of extracellular vesicles, ribonucleoprotein complexes and lipoprotein complexes. Much of the interest in exRNAs lies in the fact that they may serve as signalling molecules between cells, their potential to serve as biomarkers for prediction and diagnosis of disease and the possibility that exRNAs or the extracellular particles that carry them might be used for therapeutic purposes. Among the most significant bottlenecks to progress in this field is the lack of robust and standardized methods for collection and processing of biofluids, separation of different types of exRNA‐containing particles and isolation and analysis of exRNAs. The Sample and Assay Standards Working Group of the Extracellular RNA Communication Consortium is a group of laboratories funded by the U.S. National Institutes of Health to develop such methods. In our first joint endeavour, we held a series of conference calls and in‐person meetings to survey the methods used among our members, placed them in the context of the current literature and used our findings to identify areas in which the identification of robust methodologies would promote rapid advancements in the exRNA field.
Juvenile Idiopathic Arthritis in Olmsted County, Minnesota, 1960–2013
Krause, Megan L., Crowson, Cynthia S. , Michet, Clement J. , Mason, Thomas G. , Muskardin, Theresa Wampler , Matteson, Eric L. , Michet, C John, Mason, Thomas, Mason, Thomas

Arthritis & Rheumatology | August 28, 2015 | Volume: 68 | Issue: 1 | Pages: 247-254

10.1002/art.39323 | PMID 26316119 Get It

ObjectiveTo evaluate the incidence and prevalence of juvenile idiopathic arthritis (JIA) in Olmsted County, Minnesota in 1994–2013 and trends in juvenile rheumatoid arthritis (JRA) in 1960–2013.MethodsCases of arthritis in 1994–2013 were identified by diagnosis code with medical chart review to confirm diagnosis separately for JIA and JRA. Overall incidence rates with 95% confidence intervals (95% CIs) were age and sex adjusted to the 2010 US white population. Comparisons were made with an earlier (1960–1993) cohort from this same population.ResultsSeventy‐one incident cases of JIA in 1994–2013 were identified, with an overall age‐ and sex‐adjusted incidence rate of 10.3 per 100,000 (95% CI 7.9–12.7). Forty‐two (59%) were female, with an incidence of 12.4 per 100,000 (95% CI 8.6–16.2), as compared to 8.3 per 100,000 (95% CI 5.2–11.3) in males. The most common subtype was oligoarthritis (63%). The mean ± SD age at diagnosis was 8.2 ± 5.3 years. The prevalence of JIA on January 1, 2000 and January 1, 2010 was 51.0 per 100,000 (95% CI 25.2–76.8) and 57.6 per 100,000 (95% CI 31.0–94.5), respectively. When the annual incidence of JRA was compared over time from 1960 to 2013, there was no significant change in incidence overall; however, the incidence decreased among females (P = 0.003). A cyclic pattern of incidence was observed, with peaks approximately every 10 years. Similar to the findings with regard to incidence, prevalence did not change overall, but decreased among females (P = 0.048). There were 4 deaths in the cohort of JRA patients diagnosed in 1960–2013; the standardized mortality ratio was 1.50 (95% CI 0.41–3.83).ConclusionIncidence of juvenile arthritis overall in Olmsted County, Minnesota has not changed significantly in the past 53 years. A consistent cyclic pattern was noted.
Integration of extracellular RNA profiling data using metadata, biomedical ontologies and Linked Data technologies
Subramanian, Sai Lakshmi , Alexander, Roger P. , Cheung, Kei‐Hoi, Laurent, Louise C. , Roberts, Lewis R. , Roth, Matthew E. , Rozowsky, Joel , Su, Andrew I. , Gerstein, Mark , Kitchen, Robert , Carter, Bob S. , Laurent, Louise C , Pico, Alexander R. , Milosavljevic, Aleksandar , Roberts, Lewis R , Gerstein, Mark

Journal of Extracellular Vesicles | August 28, 2015 | Volume: 4 | Issue: 1 | Pages: No page available

10.3402/jev.v4.27497 | PMID 26320941 Get It

The large diversity and volume of extracellular RNA (exRNA) data that will form the basis of the exRNA Atlas generated by the Extracellular RNA Communication Consortium pose a substantial data integration challenge. We here present the strategy that is being implemented by the exRNA Data Management and Resource Repository, which employs metadata, biomedical ontologies and Linked Data technologies, such as Resource Description Framework to integrate a diverse set of exRNA profiles into an exRNA Atlas and enable integrative exRNA analysis. We focus on the following three specific data integration tasks: (a) selection of samples from a virtual biorepository for exRNA profiling and for inclusion in the exRNA Atlas; (b) retrieval of a data slice from the exRNA Atlas for integrative analysis and (c) interpretation of exRNA analysis results in the context of pathways and networks. As exRNA profiling gains wide adoption in the research community, we anticipate that the strategies discussed here will increasingly be required to enable data reuse and to facilitate integrative analysis of exRNA data.
Extracellular RNAs: development as biomarkers of human disease
Das, Saumya , Freedman, Jane E. , Laurent, Louise C. , Hochberg, Fred H. , Keuren‐Jensen, Kendall Van , Huentelman, Matt , Spetzler, Robert, Arango, Jorge , Adelson, P. David , Weiner, Howard L. , Gandhi, Roopali, Putterman, Chaim , Saugstad, Julie A. , Quinn, Joseph F. , Patel, Tushar , Wong, David T. , Laurent, Louise C , Carter, Bob S. , Kalani, M. Yashar S. , Goilav, Béatrice , Saugstad, Julie A

Journal of Extracellular Vesicles | August 28, 2015 | Volume: 4 | Issue: 1 | Pages: No page available

10.3402/jev.v4.27495 | PMID 26320940 Get It

Ten ongoing studies designed to test the possibility that extracellular RNAs may serve as biomarkers in human disease are described. These studies, funded by the NIH Common Fund Extracellular RNA Communication Program, examine diverse extracellular body fluids, including plasma, serum, urine and cerebrospinal fluid. The disorders studied include hepatic and gastric cancer, cardiovascular disease, chronic kidney disease, neurodegenerative disease, brain tumours, intracranial haemorrhage, multiple sclerosis and placental disorders. Progress to date and the plans for future studies are outlined.
Reproducibility and effect of tissue composition on cerebellar γ‐aminobutyric acid (GABA) MRS in an elderly population
Long, Zaiyang , Dyke, Jonathan P. , Ma, Ruoyun, Huang, Chaorui , Louis, Elan D. , Dydak, Ulrike

NMR in Biomedicine | August 28, 2015 | Volume: 28 | Issue: 10 | Pages: 1315-1323

10.1002/nbm.3381 | PMID 26314380 Get It

MRS provides a valuable tool for the non‐invasive detection of brain γ‐aminobutyric acid (GABA) in vivo. GABAergic dysfunction has been observed in the aging cerebellum. The study of cerebellar GABA changes is of considerable interest in understanding certain age‐related motor disorders. However, little is known about the reproducibility of GABA MRS in an aged population. Therefore, this study aimed to explore the feasibility and reproducibility of GABA MRS in the aged cerebellum at 3.0 T and to examine the effect of differing tissue composition on GABA measurements. MRI and 1H MRS examinations were performed on 10 healthy elderly volunteers (mean age, 75.2 ± 6.5 years) using a 3.0‐T Siemens Tim Trio scanner. Among them, five subjects were scanned twice to assess the short‐term reproducibility. The MEGA‐PRESS (Mescher–Garwood point‐resolved spectroscopy) J‐editing sequence was used for GABA detection in two volumes of interest (VOIs) in the left and right cerebellar dentate. MRS data processing and quantification were performed with LCModel 6.3‐0L using two separate basis sets, generated from density matrix simulations using published values for chemical shifts and J couplings. Raw metabolite levels from LCModel outputs were corrected for cerebrospinal fluid contamination and relaxation. GABA‐edited spectra yielded robust and stable GABA measurements with averaged intra‐individual coefficients of variation for corrected GABA+ between 4.0 ± 2.8% and 13.4 ± 6.3%, and inter‐individual coefficients of variation between 12.6% and 24.2%. In addition, there was a significant correlation between GABA+ obtained with the two LCModel basis sets. Overall, our results demonstrated the feasibility and reproducibility of cerebellar GABA‐edited MRS at 3.0 T in an elderly population. This information might be helpful for studies using this technique to study GABA changes in normal or diseased aging brain, e.g. for power calculations and the interpretation of longitudinal observations. Copyright © 2015 John Wiley & Sons, Ltd.
MicroRNA‐200 promotes lung cancer cell growth through FOG2‐independent AKT activation
Guo, Lixia , Lü, Qiang , Zhang, Ting, Yang, Yanan , Wang, Jingyu , Yang, Ping , Zhang, Ting, Yang, Yanan

IUBMB Life | August 28, 2015 | Volume: 67 | Issue: 9 | Pages: 720-725

10.1002/iub.1412 | PMID 26314828 Get It

AbstractMicroRNA‐200 (miR‐200) has emerged as a regulator of the PI3K/AKT pathway and cancer cell growth. It was reported that miR‐200 can activate PI3K/AKT by targeting FOG2 (friend of GATA 2), which directly binds to the p85α regulatory subunit of PI3K. We found that miR‐200 was elevated in early stage lung adenocarcinomas when compared with normal lung tissues, and the expression of miR‐200 promoted the tumor spheroid growth of lung adenocarcinoma cells. We show that AKT activation was essential for such oncogenic action of miR‐200. However, depletion of FOG2 had little effect on AKT activation. By performing a reverse‐phase protein array, we found that miR‐200 not only activated AKT but also concomitantly inactivated S6K and increased IRS‐1, an S6K substrate that is increased on S6K inactivation. Depletion of IRS‐1 partially inhibited the miR‐200‐dependent AKT activation. Taken together, our results suggest that miR‐200 may activate AKT in lung adenocarcinoma cells through a FOG2‐independent mechanism involving IRS‐1. Our findings also provide evidence that increased miR‐200 expression may contribute to early lung tumorigenesis and that AKT inhibitors may be useful for the treatment of miR‐200‐dependent tumor cell growth. © 2015 IUBMB Life, 67(9):720–725, 2015